Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Your most asked EOFY questions answered

Bell Direct
June 14, 2021

Weekly Wrap 11 June

Jessica Amir
June 11, 2021

Morning Bell 11 June

Jessica Amir
June 11, 2021

Morning Bell 10 June

Sophia Mavridis
June 10, 2021

Morning Bell 9 June

Jessica Amir
June 9, 2021

Morning Bell 8 June

Jessica Amir
June 8, 2021

Morning Bell 7 June

Paulina Peters
June 7, 2021

Weekly Wrap 4 June

Jessica Amir
June 4, 2021

Morning Bell 4 June

Sophia Mavridis
June 4, 2021

Morning Bell 3 June

Jessica Amir
June 3, 2021

Morning Bell 2 June

Jessica Amir
June 2, 2021